TRIUMPH-4 in participants with knee osteoarthritis showed higher rates 12.2% on 9 mg and 18.2% on 12 mg
This site is harder to self-inject and often requires assistance
Pricing Information: Provider pricing referenced on this website is sourced from publicly available information and may not reflect current rates
One controversial aspect of microdosing GLP-1s is that, when theyre taken in smaller doses, they often come from compounding pharmacies that make their own versions of FDA-approved drugs
Competition Noom competes in the digital health and weight loss market, facing competition from traditional weight loss programs, other digital health platforms, and emerging GLP-1 drug providers
Some women can experience nausea, nausea, and/or loose stools when starting, but they usually settle with gradual dose escalation